Status:

COMPLETED

Ex Vivo Cultured Bone Marrow Derived Allogenic MSCs in AMI

Lead Sponsor:

Stempeutics Research Pvt Ltd

Conditions:

Myocardial Infarction

Eligibility:

All Genders

20-70 years

Phase:

PHASE1

PHASE2

Brief Summary

This clinical trial aims to find out the safety and efficacy of adult mesenchymal stem cells in patients with myocardial infarction.

Eligibility Criteria

Inclusion

  • Patients with STEMI aged between 20 and 70 years, either males or females with non-child bearing potential, after 2 days of successful PCI.
  • Patient has global left ventricular systolic dysfunction with an ejection fraction of \<50% and \>30%.
  • ECG with sign of acute anterior MI with ST-elevation ≥ 2 mm in at least 2 of the following leads I, AVL, V1-V6, or ECG with sign of acute inferoposterior MI with ST-elevation ≥1 mm on all of the following leads- II, III, V5-V6 or STelevation ≥ 2 mm in at least 2 of the leads.
  • The target lesion located in the proximal section of the left anterior descending, left circumflex or right coronary artery.
  • Patient with acute myocardial infarction within 10 days prior to IP administration.
  • Normal liver and renal function.
  • Able to understand study information provided to him.
  • Able to give voluntary written consent.

Exclusion

  • History of acute/chronic inflammatory condition or severe aortic stenosis or insufficiency; severe mitral stenosis or severe mitral insufficiency.
  • Severe co-morbidity associated with a reduction in life expectancy of less than 1 year.
  • Advanced renal dysfunction and creatinine ≥ 2mg%.
  • Advanced hepatic dysfunction.
  • Have clinically serious and/or unstable intercurrent infection, medical illnesses or conditions that are uncontrolled or whose control, in the opinion of the Investigator, may be jeopardized by participation in this study or by the complications of this therapy

Key Trial Info

Start Date :

April 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2012

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT00883727

Start Date

April 1 2009

End Date

August 1 2012

Last Update

March 5 2013

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Care Hospital

Hyderabad, Andhra Pradesh, India, 500034

2

SAL Hospital and Medical Institute

Ahmedabad, Gujarat, India, 380054

3

MS Ramaiah Memorial Hospital

Bangalore, Karnataka, India, 560054

4

Bhagawan Mahaveer Jain Heart Centre

Bangalore, Karnataka, India, 5660052

Ex Vivo Cultured Bone Marrow Derived Allogenic MSCs in AMI | DecenTrialz